Sotagliflozacin lowers death risk and hospitalization in diabetes with HF: NEJM Dr. Kamal Kant Kohli25 Nov 2020 12:30 PM ISTAccording to the result of the trial was published in The NEW ENGLAND JOURNAL of MEDICINE on November 16, 2020 Sotagliflozin lowers total number of...
Early treatment with lorlatinib improves survival in some lung cancer patients Hina Zahid22 Nov 2020 3:45 PM ISTBOSTON - Lung cancer patients with a specific genetic alteration lived longer and were protected against metastasis to the brain when treated early...
Mass azithromycin distribution tied to antibiotic resistance among children: NEJM Dr Satabdi Saha20 Nov 2020 9:45 PM ISTAfter mass distributions of azithromycin or placebo twice yearly for 4 years, antibiotic resistance was more common in the villages that received...
Semaglutide shows promise in patients with nonalcoholic steatohepatitis: NEJM Dr Satabdi Saha18 Nov 2020 6:00 PM ISTAccording to the findings of a recently published study in New England Journal of Medicine, treatment with semaglutide resulted in a significantly...
90% of Statins related complaints are Nocebo Effect, finds clinical trial Dr. Kamal Kant Kohli16 Nov 2020 5:21 PM ISTStatins are one of the most prescribed drugs to lower LDL cholesterol and risk of cardiovascular disease in high risk patients.Most people tolerate...
Evinacumab cuts LDL cholesterol by half in high risk patients: NEJM study Dr. Kamal Kant Kohli16 Nov 2020 11:00 AM ISTResearchers at Icahn School of Medicine of Mount Sinai have found in phase 2 study that the investigational drug evinacumab reduced low-density...
Polypill plus aspirin may reduce CVD events by 31%: NEJM study Dr. Kamal Kant Kohli15 Nov 2020 3:00 PM ISTDALLAS -- Researchers have found in a large, randomized, placebo-controlled trial that a single, daily pill combining blood pressure and cholesterol...
Tocilizumab doesn't ease symptoms or prevent death in COVID-19 inpatients: NEJM Dr. Kamal Kant Kohli26 Oct 2020 4:09 PM ISTBOSTON - The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately...
Finerenone slows CKD progression in diabetes patients, finds NEJM study Dr. Kamal Kant Kohli24 Oct 2020 2:30 AM ISTResearchers have found in phase III FIDELIO-DKD trial that an investigational anti-mineralocorticoid agent slowed chronic kidney disease (CKD)...
Upadacitinib bests abracept in tough Rheumatoid Arthritis Cases: NEJM study Dr. Nandita Mohan22 Oct 2020 10:57 AM ISTUpadacitinib is an oral selective Janus kinase inhibitor to treat rheumatoid arthritis. The efficacy and safety of upadacitinib as compared with...
Rare case of autoimmune keratitis after Atezolizumab Treatment reported in NEJM Dr. Kamal Kant Kohli8 Oct 2020 10:30 AM ISTDr Joo Youn Oh at Seoul National University Hospital, Seoul, South Korea has reported a rare case of autoimmune keratitis after Atezolizumab...
Antibiotics instead of surgery better choice only for some in Appendicitis: NEJM study Dr. Kamal Kant Kohli6 Oct 2020 10:00 AM ISTResearchers with The University of Texas Health Science Center at Houston (UTHealth) have found in a first-of-its-kind clinical trial that antibiotics...
